Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market.
Lithium has been used for over half a century for the treatment of bipolar disorder as the archetypal mood stabilizer, and has a wealth of empirical evidence supporting its efficacy in this role. Despite this, the specific mechanisms by which lithium exerts its mood-stabilizing effects are not well understood.
Bipolar disorder can affect both adults and children. Lithium is prescribed to even out the moods of a person with bipolar disorder. It is often called a mood stabilizer and is sometimes prescribed for people with depression who are not responding well to other medications.